Home
Reata Pharmaceuticals, Inc.

十一月 2025的Reata Pharmaceuticals, Inc.市场份额分析

biogen is a leading global biotechnology company that pioneers science and drives innovations for complex and devastating diseases. biogen is advancing a pipeline of potential therapies across neurology, neuropsychiatry, specialized immunology and rare disease and remains acutely focused on its purpose of serving humanity through science while advancing a healthier, more sustainable and equitable world.

健康 > 生物科技及制药

域reatapharma.com

成立年份2002

员工201 - 500

年营收$15M - $25M

Reata Pharmaceuticals, Inc.

Reata Pharmaceuticals, Inc.（包含公司地区分支机构）

reatapharma.com

查看更多网站流量和参与度信息

Reata Pharmaceuticals, Inc.收入截至十一月 2025为 15M - 25M

Reata Pharmaceuticals, Inc.主要域名产生的收入

3 年中Reata Pharmaceuticals, Inc.主要域名的收入

Reata Pharmaceuticals, Inc.主要域名的收入

reatapharma.com15M - 25M

使用销售情报查看更多信息

Reata Pharmaceuticals, Inc.热门域名的总访问量

了解Reata Pharmaceuticals, Inc.市场份额和潜在市场覆盖范围。

过去 3 个月的总访问量

无数据可显示

Reata Pharmaceuticals, Inc.热门域名的平均访问时长

分析Reata Pharmaceuticals, Inc.参与度指标。

过去 3 个月的平均访问时长

无数据可显示

Reata Pharmaceuticals, Inc.热门域名的平均页面浏览量

了解Reata Pharmaceuticals, Inc.如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。

过去 3 个月的平均页面浏览量

无数据可显示

Reata Pharmaceuticals, Inc. 排名靠前的竞争对手（按域名）

十一月 2025的热门相似网站，按亲和力排名

phadia.com公司名称Phadia员工5001 - 10000总部瑞典, Uppsala年营收$200M - $500M总访问量2.5K健康 > 生物科技及制药

Reata Pharmaceuticals, Inc. 采用的主要技术

这些是排名前 Reata Pharmaceuticals, Inc. 的顶级域名所使用的网站技术（按行业分列）

转化和分析 (4)

Google Analytics

电子邮件服务 (4)

Sendgrid

社交 (4)

Instagram

小部件 (4)

Twemoji

更多技术

9

查看全部

Reata Pharmaceuticals, Inc. 的新闻与信号

借助 Similarweb 销售信号提醒，每当在目标受众之中出现新的机会或威胁时，您都会收到所识别出购买信号的每日更新。

新闻Manmeet leaves Reata Pharmaceuticals, Inc. as President, Chief Operating Officer and Chief Financial Officer.Manmeet joins us from Reata Pharmaceuticals, where he was the President, Chief Operating Officer and Chief Financial Officer.

新闻Soni leaves Reata Pharmaceuticals, Inc. as President, Chief Operating Officer, & Chief Financial Officer.Mr. Soni has over 20 years of financial and operational leadership experience and joins Summit from Reata Pharmaceuticals, Inc., where he was President, Chief Operating Officer, & Chief Financial Officer.

新闻Reata Pharmaceuticals, Inc. decreased headcount by 113 on Sep 12th '23.In a recent Worker Adjustment and Retraining Notification (WARN) notice sent to state officials in Texas, Reata said it's cutting 113 positions.

十一月 2025的Reata Pharmaceuticals, Inc.市场份额分析

Reata Pharmaceuticals, Inc.收入截至 十一月 2025为 15M - 25M

3 年中Reata Pharmaceuticals, Inc.主要域名的收入

Reata Pharmaceuticals, Inc.主要域名的收入

Reata Pharmaceuticals, Inc.热门域名的总访问量

过去 3 个月的总访问量

Reata Pharmaceuticals, Inc.热门域名的平均访问时长

过去 3 个月的平均访问时长

Reata Pharmaceuticals, Inc.热门域名的平均页面浏览量

过去 3 个月的平均页面浏览量

Reata Pharmaceuticals, Inc. 排名靠前的竞争对手（按域名）

Reata Pharmaceuticals, Inc. 采用的主要技术

转化和分析 (4)

电子邮件服务 (4)

社交 (4)

小部件 (4)

Reata Pharmaceuticals, Inc. 的新闻与信号

Reata Pharmaceuticals, Inc.收入截至十一月 2025为 15M - 25M